Dihexa
PNB-0408 · N-hexanoic-Tyr-Ile-(6)aminohexanoic amide
An extremely potent nootropic peptide (10 million times more potent than BDNF) that enhances synaptogenesis, with promising research in Alzheimer's models.
Half-Life
Not fully characterized
MW
448.6 Da
Amino Acids
N/A
Evidence
Low Evidence
Regulatory Status
Research use only. Human data very limited.
In Plain English
An extremely potent cognitive enhancer that promotes formation of new brain connections (synapses) — reportedly millions of times stronger than BDNF in lab tests. Very early research; no human safety data. Handle with extreme caution.
Overview
Dihexa is a nootropic compound derived from angiotensin IV that activates the HGF/Met system to dramatically enhance synaptogenesis (formation of new synaptic connections). It has been described as up to 10 million times more potent than BDNF for cognitive enhancement in animal models.
Common Formats
- Powder (oral or topical in DMSO)
- Injectable (research)
- Transdermal
Storage Notes
-20°C. Stable in DMSO solution.
Looking for multi-compound protocols?
Browse educational protocol discussions that include Dihexa.
Related Compounds
Educational Disclaimer: All information on this page is for educational and research purposes only. This does not constitute medical advice, diagnosis, or treatment recommendation. Consult a qualified healthcare professional.